In 2025, RSV has become a year-round concern, especially for infants and toddlers with developing lungs. With cases rising earlier in the season and lingering longer, parents across the U.S. are seeking clarity on both traditional and experimental treatments. One name that keeps surfacing—Ivermectin—has left many wondering: is it a potential solution or a risky […]